Present data suggest that IL-1α promoter is under regulatory effects of leptin through activated SP1 and NF-κB. It is known that SP1 activation augments the angiogenic and metastatic capacity of tumour cells through overexpression of multiple downstream genes, including VEGF (Shi et al, 2001). The gene discussed is IL1A; the disease is neoplasm.